Detalhe da pesquisa
1.
Phase 2a randomized clinical trial of dupilumab (anti-IL-4Rα) for alopecia areata patients.
Allergy
; 77(3): 897-906, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34460948
2.
Analysis of alopecia areata surveys suggests a threshold for improved patient-reported outcomes.
Br J Dermatol
; 187(4): 539-547, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35656793
3.
Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumab.
J Allergy Clin Immunol
; 143(1): 142-154, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30121291
4.
The impact of dupilumab treatment on SARS-CoV-2 T cell responses in atopic dermatitis patients.
Allergy
; 78(2): 571-574, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36181718
5.
Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trial.
J Am Acad Dermatol
; 78(5): 872-881.e6, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29353025
6.
The impact of dupilumab treatment on severe acute respiratory syndrome coronavirus 2-coronavirus disease 2019 antibody responses in patients with atopic dermatitis.
Ann Allergy Asthma Immunol
; 128(6): 734-736, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35346880
7.
Phase 2 randomized, double-blind study of IL-17 targeting with secukinumab in atopic dermatitis.
J Allergy Clin Immunol
; 147(1): 394-397, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32428528
8.
Combination of apremilast and narrowband ultraviolet B light in the treatment of generalized vitiligo in skin phototypes IV to VI: A randomized split-body pilot study.
J Am Acad Dermatol
; 85(6): 1657-1660, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33440217
9.
An integrated model of alopecia areata biomarkers highlights both TH1 and TH2 upregulation.
J Allergy Clin Immunol
; 142(5): 1631-1634.e13, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29981808
10.
Apremilast and narrowband ultraviolet B combination therapy suppresses Th17 axis and promotes melanogenesis in vitiligo skin: a randomized, split-body, pilot study in skin types IV-VI.
Arch Dermatol Res
; 315(2): 215-221, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35279741
11.
A phase 2a randomized vehicle-controlled multi-center study of the safety and efficacy of delgocitinib in subjects with moderate-to-severe alopecia areata.
Arch Dermatol Res
; 315(2): 181-189, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35230488
12.
Extensive alopecia areata is reversed by IL-12/IL-23p40 cytokine antagonism.
J Allergy Clin Immunol
; 137(1): 301-304, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26607705
13.
COVID-19 Symptoms Are Attenuated in Moderate-to-Severe Atopic Dermatitis Patients Treated with Dupilumab.
J Allergy Clin Immunol Pract
; 10(1): 134-142, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34737108
14.
A randomized controlled trial of oral phosphate binders in the treatment of pseudoxanthoma elasticum.
J Am Acad Dermatol
; 65(2): 341-348, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21496949
15.
Use of high-frequency, high-resolution ultrasound before Mohs surgery.
Dermatol Surg
; 36(6): 841-7, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20618368
16.
Use of 308 nm excimer laser for the treatment of chronic hand and foot eczema.
Int J Dermatol
; 55(8): e447-53, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26917041